BioGeneration Ventures
Daniela Couto joined the fund in 2015 and is a Partner at BGV. Daniela is the managing director of Staten Biotech and serves on the board of Catalym.
Daniela previously was CEO at Cell2B, a life sciences company that she co-founded dedicated to treat immune and inflammatory diseases.
Daniela holds a M.Sc. degree with honors in Biomedical Engineering from Universidade do Minho and a PhD degree with the highest honors in Bioengineering from Instituto Superior Técnico (IST) – Technical University of Lisbon and the Massachusetts Institute of Technology (MIT-Portugal Program).
This person is not in the org chart
This person is not in any offices
BioGeneration Ventures
BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €100 million of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together.